Empery Asset Management’s Cyclo Therapeutics, Inc. Warrant CYTHW Stock Holding History

Empery Asset Management’s Portfolio CYTHW Stock Details CYTHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$21K	Hold	61,399	–	–	0.13%	57
2022 Q2	$31K	Sell	61,399 -1,637	-3%	-$1.6K	0.17%	43
2022 Q1	$87K	Sell	63,036 -1,964	-3%	-$3.51K	0.41%	35
2021 Q4	$163K	Buy	+65,000	New	+$157K	0.34%	33

Other funds holding CYTHW

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Empery Asset Management's CYTHW Position: Q3 2022 in Review

Empery Asset Management held its Cyclo Therapeutics, Inc. Warrant (CYTHW) position steady in Q3 2022 at 61,399 shares worth $21K. The position accounts for 0.13% of the portfolio, ranked #57.

Empery Asset Management first reported a position in CYTHW in Q4 2021 and has held it in 4 quarters since. The position peaked at $163K in Q4 2021. 4 funds tracked by Wall St. Rank hold CYTHW as of Q3 2022.

Empery Asset Management held 61,399 shares of Cyclo Therapeutics, Inc. Warrant worth $21K as of Q3 2022.
Empery Asset Management left its Cyclo Therapeutics, Inc. Warrant share count unchanged in Q3 2022.
Cyclo Therapeutics, Inc. Warrant made up 0.13% of Empery Asset Management's portfolio in Q3 2022, its #57 holding.
Empery Asset Management first reported a position in Cyclo Therapeutics, Inc. Warrant in Q4 2021 and has held it in 4 quarters since.
Empery Asset Management's Cyclo Therapeutics, Inc. Warrant position peaked at $163K in Q4 2021.
4 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Warrant as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.